Speaker Profile

Groundbreaking work in cancer immunotherapy & development of T cell receptor (TCR) therapies for various cancers

M.D., Professor, Fred Hutchinson

Stanley Riddell is a physicianscientist at the Fred Hutchinson Cancer Center where he has contributed to the development of genemodified cell therapies for cancer.Riddell trained in medical oncology and joined the faculty at the Fred Hutchinson Cancer Center, where he established his research program. Throughout his career, Riddell has been a pioneer in the field of genemodified cell therapies, particularly CART cells. His research has focused on genetically modifying T cells to attack cancer, which has shown remarkable promise in treating leukemia and lymphoma.Riddell has also made significant contributions to the field of stem cell transplantation where he developed innovative strategies to reduce graftversushost disease. Riddell's research has earned him numerous awards and honors. He is a recipient a Research Professor of the American Cancer Society, the International Society for Biological Therapy Team Science Award, and a Hans Fischer Senior Fellow Award at the Technical University of Munich.

Next generation gene modified cell therapies for cancer
Adoptive T cell therapy holds great promise for treating refractory blood cancers. Despite high initial response rates, many patients subsequently relapse. Understanding the mechanisms of relapse has informed the development of next generation approaches that can provide more sensitive, specific, and complete elimination of cancer cells.

 Session Abstract – PMWC 2024 Silicon Valley

Track 1 - January 25 9.00 A.M.-3.00 P.M.

Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: Stanley Riddell, Fred Hutchinson
    Pioneer Honoree: George Coukos, Ludwig Cancer Center
  • Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
    Chair: Harlan Robins, Adaptive Bio
    - Stanley Riddell, Fred Hutchinson
    - Allison Betof Warner, Stanford
  • Evolving Case Law and Practical Strategies for Immunotherapy Patents
    - Janet Xiao, Morrison & Foerster LLP
  • Scientific Advancements in Individualized Cell Therapeutics for Oncology( PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - George Coukos, Ludwig Institute for Cancer Research
    - Bobert Meehan, Moderna
  • Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
    Chair: TBA
    - Amanda Pace, Sonoma Bio
  • AI-Enhanced Approaches in Gene-Modified Cell Therapy Development
    Chair: TBA
    - Brian Weitzner, Outpace Bio
    - Richard Bonneau, Prescient Design


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required